Descrizione
Estratto da Rivista xxxxx
L’approccio al paziente con declino cognitivo lieve: risultati di un’indagine in Medicina Generale
Alessandro Pirani, Raffaele Antonelli Incalzi, Giovanni Biggio, Annachiara Cagnin, Alessandra Marengoni, Camillo Marra, Ovidio Brignoli
Mild neurocognitive decline (Mild Cognitive Impairment, MCI) is a mild impairment in memory and/or other cognitive functions without repercussions
on the usual functional autonomy. The rationale for identifying MCI in General Practice is the early implementation of preventive and
therapeutic measures. A national survey was carried out to study the General Practitioners (GPs) approach to MCI with a questionnaire of
12 questions (definition, epidemiology, diagnosis, in-depth investigations, therapy). The survey was completed by 214 GPs (38% F, 51.4% > 55
years). The definition of MCI was correct in 85% of GPs: the symptoms were mainly reported by the spouse (52%). In the presence of at least
one symptom, the GPs applies psychometric tests in 47% of cases (MMSE: 60%, GPCog: 20%). The in-depth examinations prescribed are:
blood exams (64%), brain CT scan (58%), Doppler of supra-aortic trunks (46%). The therapeutic measures managed by GPs are: dietary advice,
lifestyle, therapy review, cholinergic drugs (11%) and nutrients for cognitive functions (35%). The GPs clinical approach to MCI was found to
be adequate while the therapeutic approach is more heterogeneous. It is indicated to confirm these results in a larger sample of GPs and to
promote in General Practice continuing medical education for the MCI.
Recensioni
Ancora non ci sono recensioni.